PROCEPT BioRobotics Corp (PRCT)
69.05
+3.74
(+5.73%)
USD |
NASDAQ |
May 15, 15:23
PROCEPT BioRobotics Cash from Financing (Quarterly): 2.586M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.586M |
| December 31, 2023 | 2.866M |
| September 30, 2023 | 162.12M |
| June 30, 2023 | 2.43M |
| March 31, 2023 | 0.38M |
| December 31, 2022 | -1.318M |
| September 30, 2022 | 0.777M |
| Date | Value |
|---|---|
| June 30, 2022 | 2.862M |
| March 31, 2022 | 1.291M |
| December 31, 2021 | 0.644M |
| September 30, 2021 | 174.12M |
| June 30, 2021 | 86.12M |
| March 31, 2021 | 1.225M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.318M
Minimum
Dec 2022
174.12M
Maximum
Sep 2021
33.55M
Average
2.43M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
| Globus Medical Inc | -115.72M |
| Glaukos Corp | 13.17M |
| Integra Lifesciences Holdings Corp | 358.68M |
| Intuitive Surgical Inc | -46.70M |
| Masimo Corp | -26.50M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -32.29M |
| Cash from Investing (Quarterly) | -1.946M |
| Free Cash Flow | -126.17M |
| Free Cash Flow Per Share (Quarterly) | -0.6711 |
| Free Cash Flow to Equity (Quarterly) | -34.26M |
| Free Cash Flow Yield | -3.75% |